Dynavax Technologies | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 1.66B 3.15B 2025-03
Adma Biologics USD 34.71M 2.04M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 311.2M 261M 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Dynavax Technologies USD -97875000 105.5M 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Glaxosmithkline USD 1.66B 1.78B 2024-12
Merck USD 6.77B 864M 2025-06
Neurocrine Biosciences USD 14.7M 147.9M 2025-03
Novartis USD 4.53B 124M 2025-06
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
TG Therapeutics USD 25.45M 21.18M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12


Dynavax Technologies L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.